期刊文献+

金黄色葡萄球菌肠毒素C的原核表达、纯化及活性鉴定 被引量:2

Expression,Purification and Superantigen Activity Identification of Staphylococcus aureus Enterotoxin C
下载PDF
导出
摘要 目的:在大肠杆菌中表达金黄色葡萄球菌肠毒素C(SEC),并对其活性进行检测。方法:以金黄色葡萄球菌基因组为模板扩增SEC基因,经测序正确后插入原核表达载体pBV220中,转化大肠杆菌DH5α后温度热诱导重组SEC表达;表达产物经阳离子柱纯化后,用ELISA鉴定其抗原性;通过观测表达产物对鼠脾淋巴细胞的刺激增殖情况,检测其超抗原活性。结果:构建了SEC-pBV220原核表达载体,在大肠杆菌中可快速、高效表达SEC蛋白,表达产物具有超抗原活性。结论:实现了SEC的原核表达。 Objective:To express the Staphylococcus aureus enterotoxin C(SEC) in E.coli and to analyse its superantigen activity.Methods:The gene sequence of SEC was amplified by PCR using Staphylococcus aureus genome as template.The PCR product was confirmed by sequence analysis.And then SEC-pBV220 was constructed and transformed into E.coli DH5α,and recombinant SEC protein was expressed by temperature induction and purified by CM ion-exchange chromatography.ELISA was performed to detect its immunogenicity,and the proliferation of mouse spleen lymphocyte was used to test its superantigen activity.Results:The prokaryotic expression vector SEC-pBV220 was constructed and SEC was expressed in E.coli efficiently.The expressed protein has the superantigen activity after purification.Conclusion:The protein SEC could be successfully expressed in prokaryotic expression system.
出处 《生物技术通讯》 CAS 2008年第4期512-514,共3页 Letters in Biotechnology
基金 全军"十一五"重点专题(06Z069)
关键词 金黄色葡萄球菌肠毒素C 原核表达 活性 Staphylococcus aureus enterotoxin C prokaryotic expression superantigen activity
  • 相关文献

参考文献6

二级参考文献27

  • 1金建华 王芳 陆文斌.高聚生(高聚金葡素)联合顺铂治疗恶性胸水48例临床报告[J].中国肿瘤临床,2000,27(12):928-928.
  • 2Kalland T, Dohlsten M, Lind P, et al Monoclonal antibodies and superantigens: a novel therapeutic approach. Mcd Oncol Tumor Pharmacother, 1993, 10(1-2): 37
  • 3Lando PA, Dohlsten M, Hedlund G, et al. T cellkilling of human colon carcinomas by monoclonal-antibody- targeted superantigens. Cancer Immunol Immunother, 1993, 36 (4): 223
  • 4Dohlsten M, Sundstedt A, Bjorklund M, et al. Superantigen - induced cytokincs suppress growth of human colon-carcioma cellss. Int J Caner, 1993, 54 (3)482
  • 5Ochi A, Migita K, Xu J, et al. In vivo tumor immunotherapy by a bacterial superantigen. J Immunol,1993, 151 (6): 3180
  • 6Shu S, Krinock RA, Matsumura T, et al. Stimulation of tumor- draining lymph onde cells with superantigenic staphylococcal toxins leads to the generation of turnor- specific effector T cells. J Immunol, 1994,152 (3): 1277
  • 7Belfrage H, Bhiladvala P, Hedlund G, et a1. Combined activation of murine lymphocytes with staphylococcal cnterotoxin and interleukin - 2 results in additive cytotoxic activity. Cancer Immunol Immunother,1994, 38 (4): 265
  • 8Norrby- Teglund A, Norgren M, Holm SE, et al.Similar cytokine induction profiles of a movel streptococcal cxotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun, 1994, 62 (9): 3731
  • 9Dohlsten M, Abrahmsen L, Bjork P, Monoclonal antibody- superantigen fusion proteins: tumor- specific agents for T - cell - based tumor therapy. Proc Natl Acad Sci USA, 1994, 91 (19): 8945
  • 10Ihlc J, Holzer U, Krull F, et al. Antibody - targeted superantigens induce 1ysis of major histocornpatibility complex class Ⅱ - negative T - cell leukemia lines. Cancer Res 1995, 55 (3): 623

共引文献20

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部